Business, energy, technology, markets and global industry news from Business News Today

PBC

PharmaDeviceNews PBC
Representative image of liver disease drug research and clinical data analysis. Zydus’ FDA Priority Review for saroglitazar highlights the growing treatment competition in primary biliary cholangitis.
Pharma & Biotech

Zydus gains FDA Priority Review for saroglitazar as PBC treatment competition intensifies

Zydus’ saroglitazar gets FDA Priority Review in PBC, setting up a key test for dual PPAR therapy in rare liver disease.

Read More